Assessment of gender representation in clinical trials leading to FDA approval for oncology therapeutics between 2014 and 2019: A systematic review-based cohort study
Kyle A. Dymanus, Mohit Butaney, Diana E. Magee, Amanda E. Hird, Amy N. Luckenbaugh, Merry W. Ma, Mary E. Hall, Heather L. Huelster, Aaron A. Laviana, Nancy B. Davis, Martha K. Terris, Zachary Klaassen, Christopher J.D. Wallis
Dive into the research topics of 'Assessment of gender representation in clinical trials leading to FDA approval for oncology therapeutics between 2014 and 2019: A systematic review-based cohort study'. Together they form a unique fingerprint.